As is claimed, cPAP has a growth-suppressing effect and it is due to its cellular protein tyrosine phosphatase activity and both PAP mRNA and protein levels are decreased or absent in prostate carcinoma tissue [7, 8]. Here, ACP3 is linked to prostate carcinoma.